Reduced survival after isoprenaline/dopamine in d,l-propranolol intoxicated rats

Hum Exp Toxicol. 1996 Feb;15(2):120-8. doi: 10.1177/096032719601500204.

Abstract

1. Respiratory and cardiovascular failure are principle toxic effects of beta-blocker overdose. Respiratory arrest is the primary cause of death in beta-blocker intoxicated rats. 2. The effect of beta-adrenoceptor agonists on respiratory and cardiovascular failure in beta-blocker overdose was investigated in a model of acute d,l-propranolol (30 mg kg-1 h-1) intoxication in spontaneously breathing rats. 3. Neither the aselective, hydrophilic beta-agonist isoprenaline (10, 25, 50 micrograms kg-1 min-1), nor the beta 1-selective, lipophilic beta-agonist flerobuterol (1, 3, 10 microgram kg-1 min-1) and the beta 2-selective, lipophilic beta-agonist clenbuterol (10, 25, 50 micrograms kg-1 min-1) had any beneficial effect on cardiovascular and respiratory variables or survival time in d,l-propranolol intoxicated spontaneously breathing rats. 4. Isoprenaline (10 micrograms kg-1 min-1) had no favourable effect on haemodynamic and respiratory variables in artificially ventilated d,l-propranolol intoxicated rats either. 5. Addition of dopamine to isoprenaline resulted in a significant reduction of survival time, primarily caused by a decreased in mean arterial blood pressure, in artificially ventilated d,l-propranolol intoxicated rats. Addition of glucagon to isoprenaline did not affect survival time. 6. Artificial ventilation is the most important supportive measure in d,l-propranolol intoxication in the rat.

MeSH terms

  • Adrenergic beta-Agonists / administration & dosage
  • Adrenergic beta-Agonists / pharmacology
  • Adrenergic beta-Agonists / therapeutic use*
  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / poisoning*
  • Albuterol / administration & dosage
  • Albuterol / analogs & derivatives
  • Albuterol / pharmacology
  • Albuterol / therapeutic use
  • Animals
  • Blood Gas Analysis
  • Blood Pressure / drug effects
  • Clenbuterol / administration & dosage
  • Clenbuterol / pharmacology
  • Clenbuterol / therapeutic use
  • Dopamine / administration & dosage
  • Dopamine / pharmacology
  • Dopamine / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Overdose
  • Drug Therapy, Combination
  • Glucagon / administration & dosage
  • Glucagon / pharmacology
  • Glucagon / therapeutic use
  • Heart Rate / drug effects
  • Injections, Intravenous
  • Isoproterenol / administration & dosage
  • Isoproterenol / pharmacology
  • Isoproterenol / therapeutic use*
  • Male
  • Poisoning / drug therapy
  • Poisoning / mortality
  • Propranolol / administration & dosage
  • Propranolol / poisoning*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Respiration, Artificial
  • Stereoisomerism

Substances

  • Adrenergic beta-Agonists
  • Adrenergic beta-Antagonists
  • Glucagon
  • Propranolol
  • flerobuterol
  • Isoproterenol
  • Albuterol
  • Dopamine
  • Clenbuterol